Last reviewed: June 19, 2026

Last updated: June 19, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide, a GLP-1 receptor agonist originally developed for type 2 diabetes, has demonstrated significant weight loss benefits in clinical trials, with some patients losing 15-22% of their body weight. Starting this conversation with your healthcare provider requires understanding both the mechanism and your individual eligibility. PlexusDx helps patients access compounded semaglutide from licensed 503A pharmacies while building the clinical foundation for informed discussions with their doctors.

Prepare Your Medical History Before the Appointment

Your doctor will need a complete picture of your health status before recommending semaglutide. Gather documentation of your current weight, BMI, any previous weight loss attempts, and metabolic health markers including fasting glucose, insulin levels, and lipid panel results. Include a list of all medications and supplements you're taking, as well as any family history of thyroid disease, pancreatitis, or diabetes complications.

Bring records of any previous medications you've tried for weight management, including how long you used them and what side effects you experienced. If you've had bariatric surgery or other weight-related interventions, document the timeline and outcomes. This historical context helps your provider understand why semaglutide might be appropriate for your specific situation and what dosing adjustments might be necessary.

Ask About Your GLP-1 Receptor Sensitivity and Genetic Factors

Genetic variations significantly influence how your body responds to semaglutide therapy. Ask your doctor whether genetic testing might help personalize your treatment approach. PlexusDx offers the Precision Peptide Genetic Test, which identifies key variants in your GLP1R gene and related pathways that affect medication responsiveness. This test maps 14 metabolic pathways, 49 peptides, and 150+ genetic insights to predict whether you'll be a strong or modest responder to semaglutide.

Understanding genetic factors like your GLP1R rs6923761 variant status can explain why some patients achieve rapid weight loss while others progress more gradually on the same dose. Share these insights with your provider to set realistic expectations and establish appropriate monitoring intervals. Genetic information also helps determine whether semaglutide alone is optimal or whether dual-compound approaches like tirzepatide might offer better results for your specific physiology.

Discuss Realistic Timeline and Weight Loss Expectations

Most clinical trials show initial weight loss occurs within the first 4-8 weeks, with progressive benefits continuing over 12-16 weeks as doses are optimized. Discuss with your doctor what a reasonable weight loss goal looks like for your situation—typically 5-10% of body weight in the first 3 months, with continued loss over 6-12 months. Set specific measurable targets rather than vague goals, such as losing 15 pounds by three months or reaching a certain clothing size.

Ask your doctor about the dosing schedule and whether your medication price will increase as your therapeutic dose increases. PlexusDx offers semaglutide injection starting at $149/month flat pricing across all dose levels—your dose may need to go up, but your price won't. This pricing structure removes financial surprises and lets you focus on therapeutic optimization rather than cost escalation concerns.

Prepare Questions About Side Effects and Monitoring

Gastrointestinal side effects like nausea, vomiting, constipation, and diarrhea are common during the first 2-4 weeks but typically diminish as your body adapts. Ask your doctor how to manage these symptoms through dietary modifications, hydration, and if necessary, over-the-counter remedies. Understand the difference between expected adjustment-phase effects and serious adverse events that warrant immediate medical attention, such as signs of pancreatitis, severe dehydration, or persistent abdominal pain.

Establish a monitoring plan with your doctor including regular blood pressure checks, thyroid monitoring if you have personal or family history of thyroid disease, and periodic metabolic panels. Ask about the frequency of follow-up appointments and whether they prefer telehealth visits or in-person evaluations. Clarify who to contact if you experience unexpected symptoms and whether your provider offers 24/7 support or only during business hours.

Explore Prescription Options and Treatment Access

Your doctor may prescribe brand-name Ozempic or Wegovy, but compounded semaglutide from licensed 503A pharmacies offers cost-effective access without insurance requirements. PlexusDx compounded semaglutide injection starts at $149/month and is HSA/FSA eligible, making it accessible to patients regardless of insurance status or plan limitations. Discuss with your provider whether they're comfortable with compounded medications and whether they have partnerships with specific pharmacies.

If your doctor prescribes semaglutide through PlexusDx, treatment begins immediately without membership fees or insurance approval delays. The Precision Peptide Genetic Test can be added after your first month of treatment for $99, providing personalized insights into your peptide pathway function. Ask your doctor whether genetic testing aligns with their treatment philosophy and whether they'd like to review results before adjusting your dose or considering alternative compounds.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

What should I bring to my appointment to discuss semaglutide?

Bring your current weight and height, recent bloodwork results, a list of all medications and supplements, documentation of previous weight loss attempts, and any personal or family history of thyroid disease or pancreatitis. Having your BMI calculated and a realistic weight loss goal written down helps focus the conversation on clinically appropriate outcomes. Written questions about timeline, side effects, and monitoring also ensure you don't forget important points during the discussion.

What clinical evidence should I reference when talking to my doctor?

The STEP clinical trial program demonstrated that semaglutide 2.4 mg weekly produces 14-22% weight loss over 68 weeks in patients without diabetes. Mention that GLP-1 receptor agonists work by increasing satiety, slowing gastric emptying, and improving blood sugar stability—mechanisms your doctor will recognize from diabetes treatment literature. Ask specifically about evidence related to your age, BMI category, and comorbidities, as effectiveness varies based on individual factors.

Can I use PlexusDx compounded semaglutide if my doctor prescribes it?

Yes. PlexusDx fills semaglutide prescriptions through licensed 503A compounding pharmacies and serves all 50 states without requiring insurance. Treatment starts at $149/month with no flat per-compound pricing increases, HSA/FSA eligibility, and no membership fees. Your doctor simply writes the prescription, and PlexusDx handles the coordination—they don't need a pre-existing relationship with PlexusDx to prescribe compounded semaglutide for your use.

How serious are semaglutide side effects and how long do they last?

Nausea and mild gastrointestinal upset affect 25-40% of patients during weeks 1-4 but typically resolve by week 6-8 as your body adapts. Serious adverse events like pancreatitis are rare (less than 1%) but require immediate medical attention if you develop severe abdominal pain. Discuss with your doctor whether slower dose escalation might minimize side effects in your case and what warning signs require emergency evaluation versus home management.

How does genetic testing help personalize my semaglutide treatment?

PlexusDx's Precision Peptide Genetic Test identifies variants in your GLP1R gene and related pathways that predict medication responsiveness. Knowing whether you carry variants like GLP1R rs6923761 helps explain why you might be a strong or modest responder and informs decisions about dosing speed, alternative compounds, or combination therapy. The test maps 150+ genetic insights across 49 peptides and 14 metabolic pathways—information you can share with your doctor to optimize your personalized treatment plan.

Related Reading

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake →

~60 seconds · $0 charged until your provider approves